Visser LE - Search Results

1

Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration.

Aarnoudse AJ, Dieleman JP, Visser LE, Arp PP, van der Heiden IP, van Schaik RH, Molokhia M, Hofman A, Uitterlinden AG, Stricker BH. Aarnoudse AJ, et al. Among authors: visser le. Pharmacogenet Genomics. 2008 Apr;18(4):299-305. doi: 10.1097/FPC.0b013e3282f70458. Pharmacogenet Genomics. 2008. PMID: 18334914

2

Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study.

Visser LE, Stricker BH, van der Velden J, Paes AH, Bakker A. Visser LE, et al. J Clin Epidemiol. 1995 Jun;48(6):851-7. doi: 10.1016/0895-4356(94)00231-e. J Clin Epidemiol. 1995. PMID: 7769416

3

Cough due to ACE inhibitors: a case-control study using automated general practice data.

Visser LE, Vlug AE, van der Lei J, Stricker BH. Visser LE, et al. Eur J Clin Pharmacol. 1996;49(6):439-44. doi: 10.1007/BF00195928. Eur J Clin Pharmacol. 1996. PMID: 8706767 Free article.

4

Do not give paraffin to packers.

Visser L, Stricker B, Hoogendoorn M, Vinks A. Visser L, et al. Lancet. 1998 Oct 24;352(9137):1352. doi: 10.1016/S0140-6736(98)08302-0. Lancet. 1998. PMID: 9802274 No abstract available.

5

Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease.

Visser LE, Graatsma HH, Stricker BH. Visser LE, et al. Br J Clin Pharmacol. 2002 Feb;53(2):183-8. doi: 10.1046/j.0306-5251.2001.01190.x. Br J Clin Pharmacol. 2002. PMID: 11851642 Free PMC article.

6

Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants.

Visser LE, Penning-van Beest FJ, Kasbergen AA, De Smet PA, Vulto AG, Hofman A, Stricker BH. Visser LE, et al. Clin Pharmacol Ther. 2002 Jun;71(6):496-502. doi: 10.1067/mcp.2002.124470. Clin Pharmacol Ther. 2002. PMID: 12087353

7

Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants.

Visser LE, Penning-van Bees FJ, Kasbergen AA, De Smet PA, Vulto AG, Hofman A, Stricker BH. Visser LE, et al. Thromb Haemost. 2002 Nov;88(5):705-10. Thromb Haemost. 2002. PMID: 12428081

8

Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.

Visser LE, Penning-van Beest FJ, Wilson JH, Vulto AG, Kasbergen AA, De Smet PA, Hofman A, Stricker BH. Visser LE, et al. Br J Clin Pharmacol. 2004 Apr;57(4):522-4. doi: 10.1046/j.1365-2125.2003.02036.x. Br J Clin Pharmacol. 2004. PMID: 15025752 Free PMC article.

9

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.

Visser LE, van Vliet M, van Schaik RH, Kasbergen AA, De Smet PA, Vulto AG, Hofman A, van Duijn CM, Stricker BH. Visser LE, et al. Pharmacogenetics. 2004 Jan;14(1):27-33. doi: 10.1097/00008571-200401000-00003. Pharmacogenetics. 2004. PMID: 15128048

10

The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon.

Visser LE, van Schaik RH, van Vliet M, Trienekens PH, De Smet PA, Vulto AG, Hofman A, van Duijn CM, Stricker BH. Visser LE, et al. Thromb Haemost. 2004 Jul;92(1):61-6. doi: 10.1160/TH03-12-0741. Thromb Haemost. 2004. PMID: 15213846

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters